biomarkers

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

biomarkers
Jan 13, 2025, 11:50 | Oncolibrary,Oncologist Near Me
Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer
Welcome to OncoDaily’s special section “Oncologist Near Me”, where we introduce prominent oncologists from around…
Jan 10, 2025, 15:30 | Insight
Aakash Desai: Can machine learning outperform PD-L1 as a predictive biomarker for ICI therapy in advanced NSCLC?
Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: “Can machine…
Dec 23, 2024, 12:11 | Blog
Five articles suggested by Yüksel Ürün
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…
Dec 16, 2024, 08:08 | Insight
Ben Westphalen: New biomarkers in non-colorectal dMMR tumors highlighted in NCI MATCH
Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared some…
Dec 15, 2024, 10:57 | Blog
Interesting results from the exploratory biomarker analysis of KN-522 study
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, reshared a post on…
Dec 14, 2024, 07:35 | Blog
Francisco J. Esteva: Evolving nature of HER2 biomarkers
Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…
Dec 13, 2024, 16:09 | Blog
Guilherme Nader Marta: Biomarker analyses of KN-522 shows most markers were prognostic but not predictive
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X: "Biomarker…
Dec 1, 2024, 22:10 | Blog
Ibrahim Halil Sahin: Advances in Colorectal Cancer Precision Medicine
Ibrahim Halil Sahin, Assistant Professor at UPMC Hillman Cancer Center, retweeted a post by Cancers…
Nov 25, 2024, 17:49 | Insight
Tejas Patil: Why biomarkers like PDL1 and TMB aren’t always associated with ‘hot’ or ‘cold’ immune TME
Tejas Patil, Thoracic oncologist CU Cancer Center, shared a post by Cancer Cell on X:…
Nov 20, 2024, 11:30 | Insight
Flora Xydaki: Biomarkers in Oncology - Transforming Cancer Diagnosis and Treatment
Flora Xydaki, Project Associate at BTHT, shared a post on LinkedIn: "Biomarkers in Oncology: Transforming Cancer…
Nov 3, 2024, 16:25 | Blog
Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance
ABC Global Alliance shared the following on LinkedIn: “Did you know 56% of patients didn’t…
Oct 9, 2024, 07:58 | Blog
Last chance to register for ESMO Immuno 24 in Geneva - ESMO
ESMO - European Society for Medical Oncology posted the following on LinkedIn: “ESMO Immuno 24:…
Oct 3, 2024, 00:05 | Insight
Tamoor Sial: Diving into the world of biotech content
Tamoor Sial, Business Development Manager at Inovi, shared on LinkedIn: “Diving into the world of…
Sep 27, 2024, 16:26 | Blog
New research findings reveal biological differences in sarcomas - The Institute of Cancer Research
The Institute of Cancer Research shared the following on LinkedIn: “A study led by Dr.…
Sep 16, 2024, 16:01 | Insight
Circulating miRNA as Diagnostic, Prognostic, and Predictive Biomarkers in NSCLC
A paper titled "Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive…
Sep 13, 2024, 19:00 | Blog
Brian Shields discusses TROPION-Lung01 Clinical Trial and AI’s role in content curation
Brian Shields, Creator of KOL Pulse AI, posted the following on LinkedIn: “One of the…
Sep 13, 2024, 17:10 | Insight
Insights from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Aug 26, 2024, 20:57 | Blog
The pivotal role of biomarkers in developing targeted cancer therapies - Quest Diagnostics BioPharma Services
Quest Diagnostics BioPharma Services shared a post on LinkedIn: "The role of diagnostic labs in…
Aug 16, 2024, 13:56 | Career
Michael Korn has joined Biocartis NV as its Chief Medical and Scientific Officer
Michael Korn shared a post on LinkedIn: "With great excitement, I have joined Biocartis NV,…
Aug 14, 2024, 13:00 | Insight
Elisa Agostinetto: Immunotherapy has reshaped the cancer treatment paradigm
Elisa Agostinetto shared on X: “Immunotherapy has reshaped cancer treatment paradigm, but we still need…
Aug 10, 2024, 13:49 | Dialogues
Powerful conversation about the mission of Debbie’s Dream Foundation
Debbie's Dream Foundation: Curing Stomach Cancer shared on LinkedIn: "New Interview Alert! Our CEO, Andrea…
Jul 27, 2024, 13:45 | Insight
Italo Fernandes: The role of cell-free DNA for comprehensive genomic analysis in endometrial cancer patients
Italo Fernandes, Medical Oncology Fellow at Sunnybrook Hospital, shared a post on LinkedIn: “Happy to…
Jul 14, 2024, 15:02 | Insight
Bruno Giotti: Multiple gene programs and cellular subpopulations associated with patient prognosis in pleural mesothelioma
Bruno Giotti, Postdoctoral Researcher at Icahn School of Medicine at Mount Sinai, shared a post…
Jul 11, 2024, 13:51 | Blog
Christian Rolfo: Important meeting on Drug Tolerance and Resistance in NSCLC
Christian Rolfo, Associate Director of Clinical Research Center of Thoracic Oncology at The Tisch Cancer…
Jul 6, 2024, 02:00 | Blog
The NCI PREVENT Cancer Preclinical Drug Development Program - NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared on LinkedIn: “Application deadline Monday! Are you someone actively…
Jul 4, 2024, 12:15 | Blog
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials
Angela Lamarca, HPB and NET Medical Oncologist at Jimenez Diaz Foundation, shared a post on…
Jul 2, 2024, 12:04 | Career
Luca Arecco was awarded the ASCO Conquer Cancer Merit Award
Matteo Lambertini shared a post by San Martino Hospital, Genova on X, adding: “Congrats Luca Arecco…
Jul 1, 2024, 17:27 | Blog
Bernard A. Fox: A new generation of immunotherapy clinical trials
Bernard A. Fox, Co-Founder and CEO of UbiVac shared on LinkedIn: “Great to be in…
Jun 30, 2024, 12:25 | Societies
The role of biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity
Paola Alberti, Assistant Professor of Human Anatomy at the University of Milano-Bicocca, shared on LinkedIn:…
Jun 27, 2024, 03:46 | Blog
Submit your abstract for the Molecular Analysis for Precision Oncology Congress 2024 in London - The European Society for Medical Oncology (ESMO)
The European Society for Medical Oncology (ESMO) posted on LinkedIn: “Submit your abstract for the…
Jun 18, 2024, 06:07 | Blog
Monica Bertagnolli: Insights into Molecular Basis of PTSD and Major Depression Could One Day Aid in Diagnosis and Treatment
Monica Bertagnolli shared on LinkedIn: “We know stress can take a toll on our mental health.…
Jun 14, 2024, 03:24 | Blog
Guilherme Nader Marta: Our Review On the PI3K/Akt-targeted Agents
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared on X: “PI3K/Akt-targeted agents entered…
Jun 8, 2024, 16:06 | Blog
Reflections on ASCO24 by Jill Feldman
Jill Feldman shared on X/Twitter: "1. What an honor to meet Dr. Lynn Schuchter. I'm grateful…
Jun 7, 2024, 11:58 | Blog
Yüksel Ürün: Tumor-agnostic therapies are revolutionizing oncology
Yüksel Ürün shared on X:            . "Tumor-agnostic therapies are revolutionizing…
Jun 6, 2024, 09:05 | Blog
ASCO24 trials summarized by Arndt Vogel
Arndt Vogel shared on X/Twitter: "NIVO + IPI vs LEN (90%) or SORA as 1st line…
May 22, 2024, 11:01 | Blog
Josh Atkins: Identifying Proteomic Risk Factors
Josh Atkins, Senior Cancer Genomic Epidemiologist at the Nuffield Department of Population Health of Oxford…
May 11, 2024, 10:58 | Blog
The first edition of the I.N.N.O.V.A.T.E - Neoadjuvant immunotherapy across cancers - 3P Solutions
3P Solution shared a post on LinkedIn: “REGISTRATION IS NOW OPEN! The first edition of the…
May 2, 2024, 08:36 | Insight
Chadi Hage Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
Apr 14, 2024, 07:35 | Drugs
Charles Swanton: What is the role of the TME in lung cancer evolution?
Charles Swanton, Professor at University College London Cancer Institute, shared on X/Twitter: "What is the role…
Apr 8, 2024, 22:27 | Insight
Adjuvant Therapy for Urothelial Cancer in Advances in Oncology - New Paper Alert!
Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions   Authors: Charbel Hobeika,…
Apr 8, 2024, 15:49 | Insight
Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently shared on X: "The TRAIN3…
Mar 25, 2024, 06:01 | Insight
Vivek Subbiah: For patients with NSCLC, initial use of SGT increases subsequent CGP test cancellations
Vivek Subbiah recently posted on X: "Just published in time for the ELCC24: The Impact of…
Mar 17, 2024, 19:28 | Blog
The first edition of the I.N.N.O.V.A.T.E congress will be held in Naples on July 11th and 12th, 2024 - 3P Solution
3P Solution shared a post on LinkedIn: "Great news coming up! We are organizing the…
Mar 7, 2024, 17:22 | Insight
Mohammad Jad Moussa: The new EVP 'fissure' challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Feb 1, 2024, 17:31 | Insight
Paolo Tarantino: Any agnostic approval should not stop efforts in biomarker discovery for ADCs
Paolo Tarantino, Medical Oncologist, Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter: "Of…
Jan 28, 2024, 18:29 | Blog
Elisa Agostinetto: Estradiol levels remain the biomarker of choice
Elisa Agostinetto, Clinical Research Fellow at the Institute Jules Bordet, recently shared on X/Twitter: "Out…
Jan 16, 2024, 01:08 | Blog
Renee Maria Saliby: Always grateful and fortunate to have David Braun's guidance
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, made the following…
Dec 29, 2023, 15:35 | Blog
Vivek Subbiah: Tumor-agnostic therapies advance possibilities for Precision Medicine
Vivek Subbiah shared on LinkedIn: ''Tumor-agnostic therapies advance possibilities for Precision Medicine. Genomics are driving…
Dec 10, 2023, 17:26 | Career
Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "Congratulations to Mark Awad, MD, PhD who was honored…
Nov 29, 2023, 16:26 | Blog
Top 10 abstracts to keep an eye on for SABCS 23 by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "10 days to…
Nov 3, 2023, 12:19 | Insight
Omar AbdiHamid: Our study on biomarkers of Immunotherapy response
Quoting Omar AbdiHamid, Clinical Oncology Specialist at HCGCCK Cancer Centre, on LinkedIn: ''Publication Alert. Our…
Aug 17, 2023, 16:27 | Insight
Arndt Vogel: Excellent review, many open questions, Targeting cancers with KRAS-G12D mutations.
Arndt Vogel has recently shared 0n Twitter: ''Next batter up! Targeting cancers with KRAS-G12D mutations…
Aug 3, 2023, 19:14 | Opinion
The list of biomarkers to consider Precision Medicine upfront is increasing - Pashtoon Kasi
The list of biomarkers to consider Precision Medicine upfront is increasing.  Anything you’d add to…
Jul 19, 2023, 18:24 | Blog
ADCs have changed the way we treat breast cancer and there is much more to come - Guilherme Nader Marta
ADCs have changed the way we treat breast cancer and there is much more to…
Jul 9, 2023, 09:13 | Blog
Cancer patients' access to advanced genetic testing is not keeping up with the pace of discovery of targetable mutations and personalised therapies - European Society for Medical Oncology
Jun 24, 2023, 18:00 | Blog
Orion's novel approach is the future of Precision Medicine and Cancer Research - Dr. Iyad Sultan
Pathology revolutionized: The Orion Platform , breaking new ground in high-plex spatial biology, integrates traditional…
All: 56 Posts: 1 - 100
Special Coverage